Shock Flashcards
Clinical Shock
Acute circulatory failure with inadequate or inappropriately distributed perfusion resulting in cellular hypoxia
Cellular hypoxia effect
Cells switch from aerobic to anaerobic Lactic acid production Cell function ceases + swells Membrane more permeable Electrolytes + fluids seep in + out of cell Na+/K+ pump impaired Cells swell Mitochondrial damage Cell death
Normal CO
5l/min
Normal Systolic BP
120mmHg
Mean Arterial Pressure
100mmHg
Shock diagnosis
Likely if MAP<60mmHg
Clinical signs of hypo-perfusion of vital organs (tachycardia, tachypnoea, mental confusion, pallor)
BP equation
BP = Co x systemic vascular resistance
Low CO
Either HR low or Stroke Vol low
HR controlling factors
Feedback signals from baroreceptors in carotid sinus –> activate or inhibit medullary vasomotor centres –> activate or inhibit autonomic NS
Conscious perception of arousing stimuli activates or inhibits ANS
Stroke Volume controlling factors
Amount of blood in heart before start to contract- “preload”
Myocardial contractility
Stroke volume
Volume of blood pumped from left ventricle per beat
Preload on SV
Greater the preload –> greater the force of contraction –> greater the stroke volume
Starling’s Law
The force of contraction increases as the end diastolic volume increases
Decrease in Myocardial Contractility
Cardiac disease Hypoxia/hypercapnia pH or electrolyte distribution Drugs Shock
Systemic vascular resistance
Maintained by balance between vasoconstrictors and vasodilators
Vasoconstrictors place of action
Mainly arterioles in end organs
Vasoconstrictor mechanism
1) Sympathetic NS- Release noradrenaline locally on alpha receptors on outside of arterioles
2) Angiotensin II in plasma acts on angiotensin AT1 receptor on endothelium lining arterioles –> contraction of underlying smooth muscle
Local vasoconstrictors
Released locally from endothelium
Endothelin
Local Vasoconstrictor
Prostacyclin
Vasodilator
Produced in endothelial cells from arachidonic acid
PGI2
Prostacyclin MOA
Reduces Ca entry into smooth muscle cells surrounding the endothelium
–> Reduces contractility of smooth muscle
Nitric Acid
Vasodilator
Gas
Produces in endothelial cells from arginine
Continually produced in healthy arterioles by action of moving blood on glycoproteins on the endothelial membrane
Nitric Acid MOA
Diffuses into underlying smooth muscle where it stimulates cyclic AMP formation –> decreases Ca entry and relaxes muscle
Adenosine
Released from endothelial cells + smooth muscle during activity
Vasoconstrictors
Noradrenaline
Angiotensin 2
Endothelin
5HT
Vasodilator
Prostacyclin
Nitric Oxide
Adenosine
Tissue Perfusion
Requires good CO and appropriate BP
Cardiac Output regulation
Preload
Heart Rate
BP regulation
CO
Systemic vascular resistance
Shock
Systemic vascular resistance not maintained OR
Preload decreases